Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Beovu Drug Label Revised December 2021 Was Issued in Europe, But Not in the US

January 22, 2022 By Law Offices of Thomas J. Lamb, P.A.

A “new” Beovu drug label which was revised in December 2021 sets forth some additional information about the vision-related Beovu side effects intraocular inflammation, retinal vasculitis, and retinal vascular occlusion. We point out, however, that there was no similar 2021 Beovu label change issued by Novartis in the US. From this Drug Safety … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, intraocular inflammation, occlusive retinal vasculitis, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu: Rates of Intraocular Inflammation and Retinal Vascular Occlusion

December 22, 2021 By Law Offices of Thomas J. Lamb, P.A.

A November 2021 article published by the medical journal JAMA Ophthalmology, “Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration”, provides new information about the incidence rates of intraocular inflammation and retinal vascular occlusion associated with Beovu (brolucizumab). This is our 19th article about Beovu … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, intraocular inflammation, retinal vascular occlusion, vision loss

Novartis Stops 3 Beovu Clinical Trials in May 2021, Wants a Beovu Label Change

June 8, 2021 By Law Offices of Thomas J. Lamb, P.A.

In late May 2021, the latest study data concerning Beovu safety issues resulted in Novartis stopping three key clinical trials — MERLIN, RAPTOR, and RAVEN — as well as Novartis indicating there will be another Beovu label change. To see how Novartis is seeking to present the current status of its lingering Beovu safety issues as well as the next … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, retinal artery occlusion, retinal vasculitis, vision loss

Beovu Side Effects and Beovu Lawsuits for Patients Complicate Future for Beovu

February 2, 2021 By Law Offices of Thomas J. Lamb, P.A.

Given the serious nature and number of Beovu side effects reported to date, together with the Beovu lawsuits filed against Novartis for patients with severe vision loss, it seems fair to say that things look a bit grim for Beovu and Novartis at the start of 2021. So what does the path forward look like for Beovu? Let’s start with where things … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal artery occlusion, vision loss

Beovu: What Comes Next for This Troubled Novartis AMD Eye Injection?

January 11, 2021 By Law Offices of Thomas J. Lamb, P.A.

As we start 2021, let’s look at where things currently stand with the Beovu “safety issue” — Beovu adverse drug reactions and Beovu-related eye problems — and how we got here. In the 15 months since Beovu was approved by the FDA in October 2019, there have been numerous reports of Beovu causing occlusive retinal vasculitis, retinal artery … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal artery occlusion, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu Retinal Vasculitis Made Worse by a Later Lucentis Treatment

December 21, 2020 By Law Offices of Thomas J. Lamb, P.A.

A recent medical journal article presents an interesting case report about a 76-year-old woman with Beovu-related retinal vasculitis which was made worse by a later Lucentis treatment for her wet AMD. That patient's doctors are the authors of "Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal vasculitis, vision loss

Beovu-associated Endophthalmitis is “New” for Beovu Eye Drug Safety Issue of Vision Loss

October 8, 2020 By Law Offices of Thomas J. Lamb, P.A.

In this article, we will look at the Beovu-associated endophthalmitis and Beovu-associated retinal detachment aspects of the Beovu eye drug safety issue of vision loss. New warnings for these vision-related side effects were added in June 2020 when Novartis revised the Prescribing Information for Beovu. In the Beovu drug label, or “Full … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, endophthalmitis, intraocular inflammation, occlusive vasculitis, retinal detachment, vision loss

Beovu Use Continues Despite Ongoing Beovu-associated Inflammation Investigation

October 2, 2020 By Law Offices of Thomas J. Lamb, P.A.

A summary of the Beovu-associated inflammation safety issue is presented in this July 2020 Journal of VitreoRetinal Diseases Research Article, “Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab”. From the Abstract for this item we get these details about the current Beovu safety issue under investigation: Conclusions: … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal artery occlusion, vision loss

Safety of Beovu Update: Study Results Announcement by Novartis and Beovu Label Change in Europe

September 24, 2020 By Law Offices of Thomas J. Lamb, P.A.

A September 2020 announcement by Novartis about recent Beovu study results had an emphasis on the safety of Beovu. However, this is understandable in view of a February 2020 notification issued by the American Society of Retina Specialists (ASRS) which raised questions about the safety of Beovu. We get the following from this September 14, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu: External Safety Review Committee Findings Lead To New Vision-Related Side Effects Warnings

July 9, 2020 By Law Offices of Thomas J. Lamb, P.A.

First, Novartis set up an internal review of Beovu vision-related side effects observed in the HAWK & HARRIER clinical trials, including rare post-marketing safety reports of vasculitis. In turn, new warnings for Beovu eye injections about retinal vasculitis and retinal vascular occlusion were added to the Beovu drug label. We take a closer … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal vascular occlusion, retinal vasculitis, vision loss

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.